Glial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR Imaging

PURPOSE: To evaluate the role of T2*-weighted echo-planar perfusion imaging by using a first-pass gadopentetate dimeglumine technique to determine the association of magnetic resonance (MR) imaging–derived cerebral blood volume (CBV) maps with histopathologic grading of astrocytomas and to improve the accuracy of targeting of stereotactic biopsy.

MATERIALS AND METHODS: MR imaging was performed in 29 patients by using a first-pass gadopentetate dimeglumine T2*-weighted echo-planar perfusion sequence followed by conventional imaging. The perfusion data were processed to obtain a color map of relative regional CBV. This information formed the basis for targeting the stereotactic biopsy. Relative CBV values were computed with a nondiffusible tracer model. The relative CBV of lesions was expressed as a percentage of the relative CBV of normal white matter. The maximum relative CBV of each lesion was correlated with the histopathologic grading of astrocytomas obtained from samples from stereotactic biopsy or volumetric resection.

RESULTS: The maximum relative CBV in high-grade astrocytomas (n = 26) varied from 1.73 to 13.7, with a mean of 5.07 ± 2.79 (± SD), and in the low-grade cohort (n = 3) varied from 0.92 to 2.19, with a mean of 1.44 ± 0.68. This difference in relative CBV was statistically significant (P < .001; Student t test).

CONCLUSION: Echo-planar perfusion imaging is useful in the preoperative assessment of tumor grade and in providing diagnostic information not available with conventional MR imaging. The areas of perfusion abnormality are invaluable in the precise targeting of the stereotactic biopsy.

References

  • 1 Burger PC, Vogel FS. The brain: tumors. In: Burger PC, Vogel FS, eds. Surgical pathology of the central nervous system and its coverings. New York, NY: Wiley, 1982; 223-266.
  • 2 Burger PC, Vogel FS, Green SB, et al. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985; 56:1106-1111.
  • 3 Daumas-Duport C, Scheithauer B, O'Fallon J, et al. Grading of astrocytomas: a simple and reproducible method. Cancer 1988; 62:2152-2165.
  • 4 Ringertz J. Grading of gliomas. Acta Pathol Microbiol Scand 1950; 27:51-64.
  • 5 Kelly PJ, Daumas-Duport C, Scheithauer BE, et al. Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987; 62:450-459.
  • 6 Burger P. Malignant astrocytic neoplasms: classification, pathology, anatomy, and response to therapy. Semin Oncol 1986; 13:16-20.
  • 7 Zagzag D, Friedlander DR, Dosik J, et al. Tenascin-C expression in angiogenic vessels of human astrocytomas and by human endothelial cells in vitro. Cancer Res 1996; 56:182-189.
  • 8 Brem S. The role of vascular proliferation in the growth of brain tumors. Clin Neurosurg 1976; 23:440-453.
  • 9 Ausprunk D, Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977; 14:52-65.
  • 10 Felix R, Schorner W, Laniado M, et al. Brain tumors: MR imaging with gadolinium-DTPA. Radiology 1985; 156:681-688.
  • 11 Brasch RC, Weinmann HJ, Wesbey GE. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR 1984; 142:625-630.
  • 12 Grossman I, Wolf G, Biery D, et al. Gadolinium-enhanced nuclear magnetic resonance images of experimental brain abscess. J Comput Assist Tomogr 1984; 8:204-207.
  • 13 Zhang W, Williams DS, Koretsky AP. Measurement of rat brain perfusion by NMR using spin labeling of arterial water: in vivo determination of the degree of spin labeling. Magn Reson Med 1993; 29:416-421.
  • 14 Edelman RR, Siewert B, Darby DG, et al. Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency. Radiology 1994; 192:513-520.
  • 15 Kim SG. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med 1995; 34:293-301.
  • 16 Detre JA, Leigh JS, Williams DS, et al. Perfusion imaging. Magn Reson Med 1992; 23:37-45.
  • 17 Alsop DC, Detre JA. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998; 208:410-416.
  • 18 Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191:41-51.
  • 19 Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology 1990; 176:211-220.
  • 20 Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14:249-265.
  • 21 Edelman RR, Wielopolski P, Schmitt F. Echo-planar MR imaging. Radiology 1994; 192:600-612.
  • 22 Weisskoff R, Belliveau J, Kwong K, et al. Functional MR imaging of capillary hemodynamics. In: Potchen E, eds. Magnetic resonance angiography: concepts and applications. St Louis, Mo: Mosby, 1993; 473-484.
  • 23 Press WH, Flannery BP, Teukolsky SA, et al. Numerical recipes in C: the art of scientific computing Cambridge, Mass: Cambridge University Press, 1988.
  • 24 Johnson G, Hutchison JMS. The limitations of NMR recalled-echo imaging techniques. J Magn Reson 1985; 63:14-30.
  • 25 Brem S, Cotran R, Folkman J. Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 1972; 48:347-356.
  • 26 Scherer HJ. The forms of growth in gliomas and their practical significance. Brain 1940; 63:1-35.
  • 27 Fulling KH, Garcia DM. Anaplastic astrocytoma of the adult cerebrum: prognostic value of histologic features. Cancer 1985; 55:928-931.
  • 28 Maxwell M, Naber SP, Wolfe HJ, et al. Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 1991; 51:1345-1351.
  • 29 Le Bihan D, Douek M, Argyropoulou M, et al. Diffusion and perfusion magnetic resonance imaging in brain tumors. Top Magn Reson Imaging 1993; 5:25-31.
  • 30 Weisskoff RM, Zuo CS, Boxerman JL, et al. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994; 31:601-610.
  • 31 Ernest FI, Kelly PJ, Scheithauer BW, et al. Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 1988; 166:823-827.
  • 32 Fan KJ, Kovi J, Earle K. The ethnic distribution of primary central nervous system tumors: AFIP 1958 to 1970. J Neuropathol Exp Neurol 1977; 36:41-49.

Article History

Published in print: June 1999